NCT01579500

Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients

The Effect of Botulinum Toxin A in Post Spinal Cord Injury Neuropathic Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Catholic University of Korea Saint Paul's Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in spinal cord injury patients.

Detailed description

Neuropathic pain remains a significant cause of life quality deterioration. This study includes spinal cord injury patients with refractory chronic neuropathic pain and investigates whether injection with botulinum toxin A improves pain scores.

Conditions

• Spinal Cord Injury
• Neuropathic Pain

Interventions

Type	Name	Description
DRUG	Botulinum toxin type A	Subcutaneous injection of botulinum toxin type A
DRUG	normal saline	Subcutaneous injection of normal saline

Timeline

• Start date: 2012-04-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2012-04-18
• Last updated: 2013-04-25

Locations

1 site across 1 country: South Korea